about
A network-oriented perspective on cardiac calcium signalingMetabonomic profiles delineate the effect of traditional Chinese medicine sini decoction on myocardial infarction in ratsEffects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patientsE2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated CardiomyopathyDirect Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart FailureAnalysis of Mitochondrial Proteins in the Surviving Myocardium after Ischemia Identifies Mitochondrial Pyruvate Carrier Expression as Possible Mediator of Tissue Viability.The Correlation of PPARα Activity and Cardiomyocyte Metabolism and Structure in Idiopathic Dilated Cardiomyopathy during Heart Failure Progression.Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjectsCatabolic Defect of Branched-Chain Amino Acids Promotes Heart FailureInducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouseEffects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance.Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.Insulin resistance and heart failure: molecular mechanismsMyocardial energetics in heart failure.Metabolic remodeling in chronic heart failure.Heart failure and loss of metabolic controlPleiotropic mechanisms of action of perhexiline in heart failure.The Modulating Effects of Cardiac Resynchronization Therapy on Myocardial Metabolism in Heart Failure.PET imaging in heart failure: the role of new tracers.Involvement of oxidative modification of proteins related to ATP synthesis in the left ventricles of hamsters with cardiomyopathy.Mechanical circulatory support improves diabetic control in patients with advanced heart failure.Mouse strain differences in metabolic fluxes and function of ex vivo working hearts.Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.
P2860
Q27023389-0024BA16-65A7-4597-8F6E-D273C8AAD244Q28482167-863F6E96-CE7D-4EDC-8C48-76E07FCC8076Q33647988-D6B98216-DBE7-4675-8565-01AC9800E38CQ36248883-8C0F9A2E-22B1-402E-A4CC-0AB555811645Q36367130-576E7E9A-9406-4833-BE66-1FE7796C567FQ36604135-EF74E711-D14B-4B7F-B4E7-5CAB8D2232FDQ36627766-BD456E5B-6A20-40E4-B1AD-6C19BEE8D7C3Q36797727-EB701C22-7503-4582-B0C7-8818F30101FDQ36932534-A79A86F4-5B0A-48AD-AE23-86BE0669E9DFQ36943413-539ECA66-A24D-4570-AE55-DB3954E53321Q36999950-6233B89E-3149-498E-BD54-F0FDECE0C51DQ37571935-993A1CA2-4037-4D61-8B7B-992C4CB5AF51Q38045550-0D7595C4-919E-4810-BCC4-D503A0B24A0EQ38112349-87893C41-A2A9-47E2-A4D8-F14C816D999AQ38125159-E3D6A7E6-0F67-4E55-BA67-5EFFF71EB0E3Q38171215-B44D3833-CDF4-459F-89C0-4F5D9226DBF8Q38907804-37E275B4-DAB1-42DB-8B4E-3784D7D0DB73Q38997240-170CB729-5595-4AB1-8893-03EB16BFF790Q39285234-B5F08077-39BD-4D4A-9C58-20699701D83CQ41504290-7535AAD7-63AB-40A5-B7A7-7D952EBC6DB5Q45232893-E92C7032-3CE1-4032-B599-8A10748AEFC7Q46733241-9FD961E4-F940-4F9A-9D6C-67918FF631F7Q52575994-1BEA2080-9E5F-4AD6-8274-0D9B104EFE37
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic remodelling in human heart failure.
@en
Metabolic remodelling in human heart failure.
@nl
type
label
Metabolic remodelling in human heart failure.
@en
Metabolic remodelling in human heart failure.
@nl
prefLabel
Metabolic remodelling in human heart failure.
@en
Metabolic remodelling in human heart failure.
@nl
P2860
P356
P1476
Metabolic remodelling in human heart failure.
@en
P2093
Helena Tuunanen
P2860
P304
P356
10.1093/CVR/CVR052
P577
2011-03-03T00:00:00Z